Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Resolor“
Suchtreffer
Begriffe & Kennungen
Resolor · 4.5 · Prucalopride did not inhibit specific CYP450 activities in in vitro studies in human liver microsomes at thera
Eintrag öffnenResolor · 4.5 · Prucalopride had no clinically relevant effects on the pharmacokinetics of warfarin, digoxin, alcohol, paroxet
Eintrag öffnenResolor · 4.5 · Prucalopride had no clinically relevant effects on the pharmacokinetics of warfarin, digoxin, alcohol, paroxet
Eintrag öffnenResolor · 4.5 · Prucalopride has a low pharmacokinetic interaction potential. It is extensively excreted unchanged in urine (a
Eintrag öffnenResolor · 4.5 · Prucalopride has a low pharmacokinetic interaction potential. It is extensively excreted unchanged in urine (a
Eintrag öffnenResolor · 4.5 · Therapeutic doses of probenecid, cimetidine, erythromycin and paroxetine did not affect the pharmacokinetics o
Eintrag öffnenResolor · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenResolor · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenResolor · 4.8 Undesirable effects · 1
Eintrag öffnenResolor · 4.8 Undesirable effects · 2
Eintrag öffnenResolor · 4.8 · 13 Table 1: Adverse Drug Reactions (ADRs) Associated with Resolor
Eintrag öffnenResolor · 4.8 · 4 Table 1: Adverse Drug Reactions (ADRs) Associated with Resolor
Eintrag öffnenResolor · 4.8 · Description of selected adverse reactions After the first day of treatment, the most common adverse reactions
Eintrag öffnenResolor · 4.8 · Description of selected adverse reactions After the first day of treatment, the most common adverse reactions
Eintrag öffnenResolor · 4.8 · Palpitations were reported in 0.7% of the placebo patients, 0.9% of the 1 mg prucalopride patients, 0.9% of th
Eintrag öffnenResolor · 4.8 · Palpitations were reported in 0.7% of the placebo patients, 0.9% of the 1 mg prucalopride patients, 0.9% of th
Eintrag öffnenResolor · 4.8 · Renal and urinary disorders Uncommon Pollakiuria General disorders and Common Fatigue administration site cond
Eintrag öffnenResolor · 4.8 · Renal and urinary disorders Uncommon Pollakiuria General disorders and Common Fatigue administration site cond
Eintrag öffnenResolor · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenResolor · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnen